Advanced search
Publication Cover
Current Eye Research Volume 17, 1998 - Issue 10
Submit an article Journal homepage
21
Views
22
CrossRef citations to date
0
Altmetric
Research Article

TNP-470 (a fungus-derived inhibitor of angiogenesis) reduces proliferation of cultured fibroblasts isolated from primary pterygia: a possible drug therapy for pterygia

Lidia Kria Department of Ophthalmology, Nagasaki University School of Medicine, Nagasaki, Japan
,
Akihiro Ohira Department of Ophthalmology, Nagasaki University School of Medicine, Nagasaki, Japan
&
Tsugio Amemiya Department of Ophthalmology, Nagasaki University School of Medicine, Nagasaki, Japan
Pages 986-993 | Published online: 02 Jul 2009

References

  • Deitch RD, Wilson FM. Management of pterygia. In: Bos-niak, S, ed. Principles, and Practice of Ophthalmic Plastic and Reconstructive Surgery. Philadelphia, Pa: W. B. Saun-ders Company; 1996:208–221.
  • Prabhasawat P, Barton K, Burkett G, Tseng SC. Compari-son of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmol-ogy. 1997;104:974–985.
  • Anduze AL, Burnett JIM. Indications for and complica-tions of mitomycin-C in pterygium surgery. Ophthalmic Surg Lasers. 1996;27:667–673.
  • Forster W, Atzler U, Ratkay I, Busse H. Therapeutic use of the 193-nm excimer laser in corneal pathologies. Graefe's Arch Clin Exp Ophthalmol. 1997;235:296–305.
  • Pajonk F, Flick H, Mittelviefhans H, Slamina J. Postopera-tive pterygium prevention by radiotherapy with strontium-90 beta-rays. Front Radiat Ther Oncol. 1997;30;259–264.
  • Rubinfeld RS, Stein RM. Topical mitomycin-C for ptery-gia: is single application appropriate? Ophthalmic Surg Lasers. 1997;28:662-669.
  • Kria L, Ohira A, Amemiya T. Immunohistochemical local-ization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor and tumor necrosis factor a in primary pterygium. Acta Histochem. 1996;98:195–201.
  • Kria L, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefe's Arch Clin Exp Ophthalmol. In press.
  • Marui S, Itoh F, Kozai Y, Sudo K, Kishimoto S. Chemical modification of fumagillin. I. 6-0-Acyl, 6-0-Sulfonyl, 6-0-Alkyl, and 6-0-(N-Substituted-carbamoyl) fumagillols. Chem Pharm Bull. 1992;40: 96–101.
  • Haraguchi M, Okamura M, Konishi M, et al. Anti-angio-genic compound (TNP-470) inhibits mesangial cell prolif-eration in vitro and in vivo. Kidney Int. 1997 ;51: 1838-1846.
  • Toi M, Takayanagi T, Souma R, Tominaga T. Inhibition of vascular endothelial growth factor induced cell growth by an angiogenesis inhibitor AGM-1470 in capillary endothe-lial cells. Oncology Reports. 1994;1:423–426.
  • Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature. 1990;348:555–557.
  • Kusaka M, Sudo K, Fujita T, et al. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun. 1991;174:1070–1076.
  • Castronovo V, Belotti D. TNP-470 (AGM-1470): mecha-nisms of action and early clinical development. Eur J Can-cer. 1996;32:2520–2527.
  • Yazaki T, Takamiya Y, Costello PC, et al. Inhibition of angiogenesis and growth of human non-malignant and malig-nant meningiomas by TNP-470. J Neuro-Oncol. 1995;23: 23–29.
  • Wong J, Wang N, Miller JW, Schuman JS. Modulation of human fibroblast activity by selected angiogenesis inhibi-tors. Exp Eye Res. 1994;58:439–451.
  • Levy WJ, Levy J, Clapper WE. Pterygium tissue culture: his-toimmunological study. Arch Ophthalmol. 1997;83:402–405.
  • Cornand G. Le pterygion. evolution et traitement. J Fr Ophtalmol. 1990;13:33–45.
  • Takamiya Y, Brem H, Ojeifo J, Mineta T, Martuza RL. AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo. Neurosurgery. 1994;34: 869–875.
  • Bryan G. Scaling-up of animal cell cultures. In: Freshney RI, ed. Animal Cell Culture: A Practical Approach. New York: Oxford University Press; 1992:47–93.
  • Yanase T, Tamura M, Fujika K, Kodama S, Tanaka K. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res. 1993;53: 2566–2570.
  • Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bc12 is involved. Cancer Res. 1995;55:2284–2295.
  • Khaw PT, Sherwood MB, MacKay SL, Rossi MJ, Schultz G. Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon's capsule fibroblasts. Arch Ophthalmol. 1992;110:1150–1154.
  • Kusaka M, Sudo K, Matsutani E, et al. Cytostatic inhibi-tion of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGMP-1470). Br J Cancer 1994;69:212–216.
  • Taki T, Ohnishi T, Arita N, et al. Anti-proliferative effects of TNP-470 on human malignant glioma in vivo: potent inhibition of tumor angiogenesis. J Neuro-Oncol. 1994; 19:251–258.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.